10 Best AI for Pharma & Biotech Courses [2026 June] [MIT | NUS | Long Island]

Artificial intelligence is transforming the pharmaceutical and biotech landscape with unprecedented speed and precision. From AI-powered drug discovery and molecular modeling to biomarker identification, clinical trial simulation, and patient stratification, AI technologies are redefining every stage of the life sciences innovation cycle. By leveraging machine learning, neural networks, and generative algorithms, pharmaceutical companies are reducing time-to-market, improving treatment outcomes, and optimizing R&D spend. In biotech, AI accelerates target identification, predicts disease progression, and enhances real-world data analysis. These advancements are not just boosting operational efficiency—they’re unlocking entirely new therapeutic approaches and reshaping how the industry approaches personalized medicine, diagnostics, and regulatory compliance.

At Digitaldefynd, our goal is to help life sciences professionals stay ahead of the curve through a curated selection of the Best AI for Pharma and Biotech Courses. This includes industry-leading programs like Artificial Intelligence in Pharma and Biotech from MIT Sloan, Artificial Intelligence in Healthcare from MIT xPRO, and AI for Healthcare from the National University of Singapore. Whether you’re a biotech executive, clinical data scientist, or pharmaceutical strategist, these courses provide the frameworks and tools to harness AI effectively and drive innovation within your organization. Explore the list to find a program that aligns with your goals—and take the next step toward becoming an AI leader in life sciences.

 

Best AI for Pharma & Biotech Courses [2026 June]

Artificial Intelligence in Pharma and Biotech (MIT)

The Artificial Intelligence in Pharma and Biotech program from the MIT Sloan School of Management is one of the most advanced and impactful AI courses tailored for professionals in the life sciences industry. Offered as a fully online, six-week program, it delivers a strategic blend of technical depth and industry-specific application, making it ideal for scientists, data analysts, biotech executives, and pharmaceutical innovators. Participants engage in a highly relevant and well-structured curriculum that covers AI-driven approaches to drug discovery, clinical trials, disease modeling, and biomarker development—core areas where machine learning is driving transformation.

What makes this course exceptional is its strong integration of AI techniques with real-world biotech and pharma use cases. Learners explore how neural networks and generative models are revolutionizing molecular design and how AI tools assist with patient stratification, health monitoring, and therapeutic targeting. Faculty leadership includes Regina Barzilay, a world-renowned authority in AI for molecular and clinical applications, along with a multi-disciplinary team of MIT experts in systems biology, computer science, and data-driven healthcare. Through a mix of video lectures, case-based assignments, peer interaction, and faculty-led instruction, participants build a cross-functional toolkit to drive innovation within their organizations.

The course is particularly well-suited for professionals looking to bridge the gap between technical machine learning concepts and strategic business impact. It offers a hands-on learning experience where learners apply advanced techniques in generative biology, real-world data modeling, and clinical trial simulation. It also emphasizes how to assess and implement AI across R&D pipelines, commercialization pathways, and operational frameworks in biopharma environments. Graduates not only gain a prestigious digital certificate from MIT Sloan but also emerge with the confidence and capability to guide AI adoption within high-stakes scientific and regulatory contexts.

 

Highlights:

– Earn a digital certificate of completion from the globally respected MIT Sloan School of Management

– Learn from elite MIT faculty like Regina Barzilay and Caroline Uhler, who are pioneering AI applications in health, biology, and data science

– Gain practical knowledge in early-stage drug discovery, including small molecule modeling and biologics development using generative AI

– Model disease mechanisms with AI using perturbational data, transcriptomics, single-cell technologies, and cell imaging frameworks

– Use machine learning tools to enhance patient stratification, predict treatment responses, and design more efficient, inclusive clinical trials

– Analyze case studies such as the Johnson & Johnson COVID-19 vaccine trial to understand the real-world impact of synthetic controls and ML-driven site selection

– Develop a business roadmap for integrating AI across pharmaceutical R&D, operations, and product strategy

– Engage in peer discussions, interactive assessments, and guided weekly modules supported by a dedicated learning success team

 

Mode: 100% Online – Self-paced with live interactions, rich media content, and practical assignments

Duration: 6 weeks, with a recommended effort of 6–8 hours per week

Rating: 4.8 out of 5

You can Sign up Here

 

 

Pharm.D. & MS in Artificial Intelligence (LIU Pharmacy)

The Pharm.D. & MS in Artificial Intelligence dual-degree program at LIU Pharmacy is a pioneering academic pathway tailored for future pharmacy leaders ready to embrace the transformative potential of AI in biomedicine. This integrated program equips students with the unique ability to bridge pharmacy practice with cutting-edge computational intelligence, making it highly relevant for those targeting roles in biotech innovation, digital health, and data-driven pharmaceutical R&D. With the convergence of health sciences and machine learning accelerating, the program is designed to future-proof graduates for the AI-powered pharma landscape.

Students earn a Doctor of Pharmacy alongside a Master’s in Artificial Intelligence through a rigorous, interwoven curriculum that emphasizes both clinical acumen and advanced AI competencies. The AI component spans 30 credits and includes coursework in deep learning, biomedical data mining, autonomous robotics, and computational neuroscience. These are supplemented by modules on machine learning, natural language processing, and pattern recognition—all contextualized for healthcare and pharmaceutical applications. A dual thesis or non-thesis track further enhances flexibility, with research work often addressing real-world industry or healthcare system problems.

 

Highlights:

– Gain dual credentials (Pharm.D. and MS) from a recognized leader in pharmacy education with deep integration of AI capabilities

– Build a strong foundation in applied machine learning, deep learning architectures, data visualization, and speech recognition with direct applications in health tech.

– Explore domain-specific AI in modules such as Computational Neuroscience & Cognition, Bioinformatics, and Vision Computing.

– Program structure supports concurrent progress through both degrees, minimizing time-to-completion while maximizing career readiness.

– Choose from electives across AI, Computer Science, and Data Analytics to tailor your expertise to specific interests like drug discovery, hospital automation, or regulatory tech.

– Research-focused students can pursue AI-led thesis work under faculty guidance, leveraging computational tools to solve challenges in pharmacology, genomics, or public health.

– Non-thesis students can opt for additional electives in advanced AI topics and practical projects involving pharmacy system modeling and real-time diagnostics.

– Courses such as AI 700: Applicable Deep Learning and AI 690: Autonomous Robotics offer hands-on lab experiences and simulation-based learning environments

– Graduates are positioned for roles across clinical informatics, biotech startups, health data platforms, AI labs, regulatory science, and more.

 

Mode: On-campus (Brooklyn, NY) with AI coursework integrated throughout Pharm.D. schedule

Duration: 5 years (including both Pharm.D. and MS components); 21 additional AI credits outside the core Pharm.D. curriculum

Rating: 4.8 out of 5

You can Sign up Here

 

 

Artificial Intelligence in Healthcare: Fundamentals and Applications (MIT xPRO)

The Artificial Intelligence in Healthcare: Fundamentals and Applications course by MIT xPRO is an exceptional fit for professionals in the pharmaceutical and biotech sectors who are eager to harness AI for accelerated research, clinical innovation, and data-driven decision-making. Spanning 7 weeks, this online program provides a strategic and technical roadmap for leveraging AI tools in areas such as drug discovery, genomic analysis, personalized medicine, and predictive diagnostics. Developed and taught by MIT faculty, the course offers deep insights into cutting-edge technologies that are actively reshaping pharma and biotech workflows.

Participants gain practical exposure to AI product design, machine learning algorithms, and advanced neural networks, all tailored to healthcare applications. The program also introduces learners to emerging tools like ingestible robots and biomechatronic systems—technologies that are becoming increasingly relevant in drug delivery and rehabilitative biotechnology. Through hands-on simulations, case studies (e.g., antibiotic discovery using Graph Neural Networks), and Python-based exercises, participants acquire the skills to lead AI projects from concept to implementation within pharma and biotech environments.

 

Highlights:

– Earn a certificate of completion and 3.50 CEUs from MIT xPRO, boosting your credibility in AI-driven life sciences innovation

– Apply machine learning and deep learning to real-world pharmaceutical challenges such as compound screening, genetic profiling, and treatment optimization

– Design AI products aligned with regulatory, ethical, and clinical trial standards using a four-stage design framework

– Analyze case studies involving breast cancer prediction, genetic predisposition mapping, and Wi-Fi-based patient monitoring for pharma adherence programs

– Learn how to leverage tools like the Peloton framework and Jupyter Notebooks to prototype AI solutions for R&D and therapeutic pipelines

– Solve biotech-specific challenges in capstone projects, including the creation of smart prosthetics and simulation of superhuman AI for medical tasks

– Receive live faculty interaction, peer feedback, and expert support to strengthen your leadership in AI-pharma integration

– Experience a blend of asynchronous content and interactive modules including quizzes, Decide-It activities, and crowdsource simulations

 

Mode: Online, with weekly live sessions and on-demand content

Duration: 7 weeks (5–7 hours per week)

Rating: 4.6 out of 5

You can Sign up Here

 

 

Bonus – Quick Comparison Guide to Best AI for Pharma & Biotech Courses

Program	Institution	Duration	Format	Best Suited For
Artificial Intelligence in Pharma and Biotech	MIT Sloan School of Management	6 weeks	100% online	Pharma, biotech, R&D, and data professionals focused on AI in drug discovery, clinical trials, disease modeling, and biomarkers.
Pharm.D. & MS in Artificial Intelligence	LIU Pharmacy	5 years	On-campus	Future pharmacy leaders seeking dual clinical and AI expertise for biotech, digital health, informatics, and pharma R&D roles.
Artificial Intelligence in Healthcare: Fundamentals and Applications	MIT xPRO	7 weeks	Online	Healthcare, pharma, and biotech professionals looking to apply ML, neural networks, and AI product design to clinical and research use cases.
Healthcare Leadership	Stanford Center for Health Education	8 weeks + orientation	Online, self-paced	Healthcare and life sciences leaders managing teams, change, and AI-enabled transformation across complex organizations.
AI for Senior Executives	MIT xPRO	6 months	Blended	Senior pharma, biotech, and healthcare executives building AI strategy, governance, product roadmaps, and transformation plans.
Artificial Intelligence in Health Care	MIT Sloan School of Management	6 weeks + orientation	Online	Pharma, biotech, clinical, and medical affairs professionals applying AI to diagnostics, NLP, risk prediction, and clinical workflows.
Leadership Program in Medical Technology and AI	MIT xPRO	26 weeks	Online	Medtech, pharma, biotech, and digital health leaders working on AI-enabled innovation, diagnostics, regulation, and commercialization.
Executive Program for Senior Life Sciences Leaders	Harvard Medical School Executive Education	8 months	Live online	Senior life sciences executives leading AI, RWE, digital therapeutics, drug development, and organizational transformation.
Leading Digital Transformation in Health Care	Harvard Medical School Executive Education	6 weeks	Fully online	Healthcare, pharma, and biotech leaders building digital health, AI, IoT, blockchain, and transformation roadmaps.
Healthcare Management	Yale School of Management	8 weeks + orientation	Fully online, self-paced	Clinicians, pharma, biotech, and healthcare managers needing business, finance, compliance, and operations foundations for AI-era healthcare leadership.

 

 

Healthcare Leadership (Stanford | Center for Health Education)

The Healthcare Leadership program by Stanford Center for Health Education is an elite online course designed to strengthen the leadership capabilities of healthcare and biotech professionals navigating fast-changing environments. Over eight weeks, the program empowers participants with evidence-based frameworks, decision-making strategies, and communication techniques necessary for driving innovation, leading teams, and managing change in complex healthcare organizations. With a curriculum rooted in the latest leadership science and healthcare practice, the course is well-suited for professionals overseeing AI-driven transformation in pharma, health systems, or digital medicine.

Led by renowned Stanford faculty, including Dr. Nirav R. Shah—a leader in digital health and health systems innovation—the program blends high-impact modules with real-world scenarios and self-paced learning. Participants explore how leadership principles apply to areas like clinical operations, crisis communication, systems improvement, and change management. While not explicitly focused on AI technologies, it offers valuable strategic and organizational insights for pharma and biotech leaders steering AI-enabled initiatives across drug development, diagnostics, and healthcare delivery.

 

Highlights:

– Build leadership resilience by mastering time-energy management, vulnerability-based collaboration, and trust-building in cross-disciplinary healthcare teams.

– Learn to lead change through frameworks like Six Sigma, Agile, and OKRs—critical for structuring AI adoption within healthcare or life sciences organizations.

– Enhance team performance and communication using shared decision-making models and rapid response strategies.

– Navigate high-stakes environments using structured decision-making tools such as the RAPID framework and mental model analysis.

– Create a personalized leadership development plan and an impactful narrative for driving transformation using data-backed storytelling.

– Understand the intersection of crisis response, system dynamics, and healthcare communication—relevant to AI integration and digital transformation.

– Engage with world-class academic content, including case studies, video lectures, experiential exercises, and interactive infographics.

– Benefit from continuous guidance by expert tutors and access to the 2U Career Engagement Network, offering job search tools, career events, and networking resources

– Earn a digital certificate from the Stanford Center for Health Education upon successful completion.

 

Mode: Online, self-paced with 6–9 hours per week

Duration: 8 weeks (plus 1-week orientation)

Rating: 4.7 out of 5

You can Sign up Here

 

 

AI for Senior Executives (MIT xPRO)

The AI for Senior Executives program by MIT xPRO is a premier, six-month blended executive education experience tailored for senior decision-makers aiming to lead AI transformation across industries—including healthcare, pharma, and biotechnology. With a practical, business-first focus, the program prepares leaders to implement AI-driven strategies that align with organizational goals, from product innovation to operational efficiency. Anchored by MIT’s world-renowned CSAIL faculty, this course is particularly valuable for life sciences professionals aiming to translate AI potential into measurable outcomes.

Participants gain hands-on experience designing AI product strategies, developing implementation roadmaps, and mastering the organizational, regulatory, and ethical aspects of AI deployment. The curriculum covers the full spectrum of AI leadership—from machine learning and deep learning fundamentals to generative AI, HCI, and governance. Through in-person immersions at MIT, live online sessions, and peer collaboration, executives build a board-ready AI strategy tailored to their company’s transformation agenda.

 

Highlights:

– Design and execute an AI strategy aligned with business and R&D priorities, using a customized roadmap activity tailored to your enterprise challenges.

– Understand how to architect intelligent products using AI, machine learning, deep learning, and generative models—critical for AI-enabled biotech and pharma innovation.

– Explore AI adoption at scale, including frameworks for team readiness, security, regulation, and digital transformation of workforces.

– Learn directly from MIT CSAIL pioneers and senior MIT faculty across engineering, business, and media labs, including Prof. Daniela Rus and Dr. Thomas Malone.

– Apply leadership techniques for fostering agility, innovation culture, and stakeholder buy-in—crucial for driving AI across regulated industries

– Participate in an in-person capstone immersion on MIT’s campus, connecting AI strategy to product execution, regulatory context, and ROI measurement.

– Benefit from a dedicated success coach, program experience manager, and optional summer networking event with global executives

– Ideal for executives across pharma, biotech, health services, R&D, strategy, operations, and digital transformation roles

– Receive a verified certificate of completion from MIT xPRO, signaling executive-level fluency in AI for business and product innovation.

 

Mode: Blended (online, live online, and in-person at MIT campus)

Duration: 6 months

Rating: 4.6 out of 5

You can Sign up Here

 

 

Artificial Intelligence in Health Care (MIT)

The Artificial Intelligence in Health Care online short course by MIT Sloan School of Management is a top-tier choice for professionals in the pharmaceutical and biotechnology industries aiming to harness AI for innovation, R&D efficiency, and operational excellence. This 6-week program, created in collaboration with the MIT J-Clinic, delivers an in-depth exploration of AI technologies—including machine learning, deep learning, and natural language processing—applied to clinical development, diagnostic innovation, and data management. It equips pharma and biotech leaders with the analytical and strategic capabilities needed to lead AI transformation across the drug discovery and healthcare value chain.

Participants gain firsthand insight into how AI is accelerating breakthroughs in disease modeling, treatment personalization, and clinical trial optimization. Through real-world case studies and expert instruction from MIT’s world-renowned faculty, the program enables learners to assess AI tools for risk stratification, medical literature analysis, and clinical workflow augmentation—capabilities that directly support decision-making in R&D pipelines and regulatory science. Pharma executives, medical affairs leaders, and biotech strategists will benefit from this program’s practical, interdisciplinary framework for AI deployment.

 

Highlights:

– Earn a certificate of completion from MIT Sloan School of Management, a global leader in business and innovation

– Gain fluency in core AI concepts—supervised learning, neural networks, NLP—tailored to life sciences and clinical applications

– Study breakthrough use cases in oncology diagnostics, disease prediction, and AI-guided treatment planning

– Leverage NLP and data analytics to mine value from unstructured clinical and scientific data, including pathology reports and medical literature

– Understand interpretability and compliance challenges associated with deploying AI in regulated pharma/biotech environments

– Apply an AI decision framework to prioritize use cases across clinical development, pharmacovigilance, and trial optimization

– Learn from top MIT faculty including AI leaders Regina Barzilay, Dimitris Bertsimas, Tommi Jaakkola, and others with experience across healthcare and biotech domains

– Access dedicated support from facilitators, success advisers, and a 24/7 global tech team to ensure seamless learning

– Network with a global cohort of health tech, pharma, and clinical professionals driving innovation in life sciences

 

Mode: Online, with weekly modules and interactive case-based learning

Duration: 6 weeks (plus 1-week orientation)

Rating: 4.7 out of 5

You can Sign up Here

 

Related: Role of CTO in Healthcare Sector

 

 

Leadership Program in Medical Technology and AI: Leading Healthcare Innovation Globally (MIT xPRO)

The Leadership Program in Medical Technology and AI by MIT xPRO ranks among the best executive education options for professionals working at the convergence of artificial intelligence, biotech, and pharmaceutical innovation. Delivered fully online over 26 weeks, with 4–6 hours of weekly study, the program offers an MIT-verified digital certificate and delivers executive-level insight into how AI is transforming product development, clinical diagnostics, digital health, and operational efficiency across life sciences and healthcare.

Participants explore the end-to-end lifecycle of health innovation—spanning product strategy, regulatory navigation, clinical validation, reimbursement, and AI-driven performance enhancement. AI applications are woven throughout the curriculum, from diagnostics and biomarkers to machine learning for decision support, intelligent automation, and software-enabled medical technologies. The capstone project challenges learners to propose a scalable, AI-augmented solution to a real clinical or organizational challenge—an approach especially relevant to pharma and biotech leaders bringing AI into drug discovery, clinical trial design, and personalized medicine.

 

Highlights:

– Earn a verified digital certificate from MIT xPRO, solidifying your credibility in healthcare AI and biotech-driven leadership.

– Learn how AI drives innovation across diagnostics, clinical trials, wearables, and healthcare operations, including modules focused on machine learning, decision support tools, and software-integrated medical devices.

– Gain business fluency in reimbursement, IP, FDA design controls, and regulatory alignment, equipping you to take biotech or AI-driven therapies from R&D to market.

– Learn from globally respected MIT faculty and over 10 healthcare and AI experts, including Dr. Michael J. Cima, Dr. Deborah Ancona, and Bruce Lawler, Managing Director of MIT Machine Intelligence for Manufacturing and Operations.

– Participate in live sessions, peer forums, and an optional 2-day networking event at MIT, building global connections across pharma, biotech, medtech, and digital health sectors.

– Complete a capstone project, applying AI to solve a clinical or operational challenge, with attention to market size, IP, reimbursement, and regulatory requirements.

 

Mode: 100% Online (with optional in-person networking event)

Duration: 26 weeks, 4–6 hours per week

Rating: 4.8 out of 5

You can Sign up Here

 

 

Executive Program for Senior Life Sciences Leaders (Harvard Medical School | Executive Education)

The Executive Program for Senior Life Sciences Leaders by Harvard Medical School Executive Education is a transformative 8-month online program designed specifically for executives at the forefront of pharma, biotech, and health innovation. Amid sweeping changes driven by AI, real-world data, digital therapeutics, and new value-based care models, this program provides the strategic, technological, and leadership skills needed to guide life sciences organizations through innovation and uncertainty. It is uniquely positioned to serve those navigating AI adoption across clinical development, regulatory alignment, and therapeutic innovation.

Through a blend of live sessions, case studies, capstone leadership projects, and Harvard’s signature decision-making frameworks, the program empowers life sciences leaders to accelerate drug development, integrate AI and digital health tools, and build agile, evidence-driven organizations. The curriculum spans AI’s role in R&D, access and equity strategies, patient engagement, and organizational culture—equipping participants to lead in data-rich, high-stakes environments.

 

Highlights:

– Gain expert insights on how AI-first biotech firms are reshaping drug discovery pipelines—75% of such companies already use AI extensively.

– Understand and apply AI, digital therapeutics, and real-world evidence (RWE) to streamline clinical development, optimize trials, and enhance patient-centricity

– Use cutting-edge frameworks—such as Digital Therapeutics Strategy, RWD Applications, and New Product Development—to guide innovation and strategic planning.

– Explore modules like Artificial Intelligence in the Life Sciences Industry, Digital Tools in Drug Development, and Best Practices for Using RWE.

– Collaborate with global peers through interactive sessions and a culminating capstone project aligned to your organizational goals.

– Learn directly from Harvard faculty and industry experts, including Dr. Stanley Shaw (Amgen), Margaret Andrews, and AI specialists from Lila Sciences and Datavant.

– Enhance leadership through modules on emotional intelligence, negotiation, change management, and leading high-performing teams.

– Receive a digital Certificate of Completion from Harvard Medical School Executive Education upon meeting requirements.

 

Mode: Live online with flexible pacing and optional in-person networking

Duration: 8 months

Rating: 4.5 out of 5

You can Sign up Here

 

Related: Why and How to Learn Artificial Intelligence

 

 

Leading Digital Transformation in Health Care (Harvard Medical School | Executive Education)

The Leading Digital Transformation in Health Care program by Harvard Medical School Executive Education is a powerful six-week online course that addresses how digital technologies—including AI, IoT, and blockchain—can be strategically deployed to improve health care systems. Designed for executives, clinical leaders, and life sciences innovators, the program delivers practical frameworks and a global lens on leveraging digital health solutions for cost efficiency, patient-centricity, and system-wide transformation. This course is especially valuable for pharma and biotech leaders tasked with aligning digital health innovations with product lifecycle management and therapeutic impact.

Participants learn to differentiate meaningful digital innovations from hype, understand the critical enablers of digital adoption, and build a transformation roadmap tailored to their organizational goals. Through global case studies—spanning pharma, hospitals, and health tech firms—alongside expert faculty and peer discussions, the program explores how AI and digital infrastructure can scale clinical innovation, streamline operations, and enable real-time patient engagement.

 

Highlights:

– Master digital strategy and change leadership through modules on AI, blockchain, IoT, and transformation management across health care systems

– Apply frameworks to evaluate technology viability, build the business case, and manage digital innovation in regulated and risk-sensitive environments.

– Explore case studies featuring Boehringer Ingelheim, Australian personal health records, U.K. NHS standardization, and U.S. health systems digitalization.

– Develop a capstone digital transformation plan specific to your organization’s context, covering goals, tools, governance, innovation, and impact realization.

– Receive guidance from Dr. John Glaser (former CIO, Partners HealthCare) and a global panel of guest speakers from institutions like Providence, Beth Israel, and Boehringer Ingelheim.

– Gain exposure to real-world digital maturity models and cross-industry comparisons to benchmark pharma and biotech transformation readiness.

– Engage in peer learning and networking through live office hours, playbook exercises, and project feedback in a global, cohort-based format.

– Earn a verified digital certificate from Harvard Medical School Executive Education upon completion.

 

Mode: Fully online with live sessions and recorded lectures

Duration: 6 weeks

Rating: 4.6 out of 5

You can Sign up Here

 

 

Healthcare Management (Yale School of Management)

The Healthcare Management program from Yale School of Management Executive Education offers a robust, eight-week online learning experience tailored for professionals seeking to bridge clinical expertise with essential business and leadership skills. This course is especially valuable for pharma and biotech professionals, clinicians, and health service leaders who need to navigate organizational strategy, finance, compliance, and operations within a healthcare setting increasingly influenced by AI and digital transformation. It provides foundational business acumen applicable to those managing AI-driven health systems, private practices, or research-based healthcare units.

Led by Dr. Paul Taheri—former CEO of Yale Medicine—the program introduces participants to cost reporting, reimbursement models, capital budgeting, compliance, and performance improvement, with real-world healthcare case studies. The course also emphasizes how efficient operations, informed financial decisions, and physician leadership can collectively improve care delivery and system performance.

 

Highlights:

– Understand healthcare economics, cost structures, and margin reporting to support data-driven decision-making in clinical and biotech operations.

– Master U.S. reimbursement frameworks, hospital funding systems, and physician compensation models—essential for professionals managing AI-enabled billing or RCM tools

– Explore operations management techniques, such as Little’s Law, for improving throughput and reducing variability in healthcare delivery systems.

– Learn legal safeguards and conflict resolution frameworks relevant to clinical quality, AI-driven diagnostics, and regulatory compliance.

– Gain exposure to financial planning, capital budgeting, and stewardship principles necessary for long-term investments in digital or AI infrastructure.

– Analyze group practice models, physician accountability frameworks, and market-entry strategies for structuring healthcare or biotech service offerings.

– Translate management knowledge into effective leadership, particularly relevant for clinicians or scientists evolving into executive roles.

– Receive a certificate of participation from Yale School of Management Executive Education upon successful completion.

 

Mode: Fully online, self-paced

Duration: 8 weeks (plus 1-week orientation), 5-7 hours per week

Rating: 4.5 out of 5

You can Sign up Here